English Information

Icon Gesundheitswissenschaften und Medizin

Master's program

Clinical Research, M.Sc.


Start of the program: 2018, December 01
Credit-points: 60
Degree: Master of Science
Tuition fees: 17,000.00 EUR (incl. fees for the PPCR program) / 8,500.00 EUR for PPCR-Graduates

Contact

Dipl.-Volksw. Simone Krautz

Tel:  0351 40470-121
Fax: 0351 40470-110
clinical.research@di-uni.de


accredited by ZEvA

Our mission is to provide research training around the globe

The Dresden International University (DIU) Master’s Program in Clinical Research (MPCR) is designed to provide training in the methodology and practice of clinical research and create an international platform for medical scientists which is strongly based on teamwork, creativity, out-of-the-box-thinking and multidisciplinary collaboration. Our program allows alumni from the Principles and Practice of Clinical Research (PPCR) course to obtain a Master of Science degree within one additional year of training.  PPCR is a collaborative distance-learning training program offered by Harvard TH Chan School of Public Health. We recognize all grades and evaluations obtained during PPCR as equivalent to ECTS. Thus we created a highly efficient integrative educational program during which students receive the academic title Master of Science (MSc) from Dresden International University after having received a PPCR course certificate from Harvard Medical School and the academic title Master of Science (MSc) from Harvard TH Chan School of Public Health.

Students receive personalized intensive training in presenting themselves and their research in a competitive international environment. In fact, training of presenting skills including intensive mentoring in presenting clinical research data is one of our key components during MPCR.

We encourage our students to submit a research or review paper as Master’s thesis. Thus, students do not have to draft an actual 100-page long thesis to complete our program but can submit a DIU-supervised research project and get published instead. This creates an outstandingly beneficial situation where students improve their manuscript writing skills, enhance their publication track record, and avoid writing a regular thesis.

Our program faculty includes internationally recognized senior researchers and leaders of their fields from Germany, the United States, the United Kingdom and other countries.

Our lecturers do not just give teacher centered lectures but rather collaborate with you to generate new ideas and research questions, develop new thinking strategies and help you further develop your individual skills. This unique and very close and open relationship between students and teachers is also a mutually beneficial way of exchanging ideas and creating a strong professional network.

During MPCR students will work closely with DIU staff and lecturers in classes, workshops and during preparation of the master’s thesis. The goal is to translate previously learned knowledge into practice and help students with scientific presentation and writing.

Description of the PPCR course (offered by Harvard TH Chan School of Public Health)

This collaborative and interactive distance-learning program in clinical research is offered to participants from Boston and throughout the world. The program is designed for individuals who wish to gain basic and advanced training in clinical trials before moving into the field and for those who have experience in this area and aim to expand their role in designing, managing, analyzing, and reporting the findings of clinical trials.

Main Course Program Overview

(for detailed program go to www.hsph.me/ppcr)

The goal of the Master in Clinical Research Program is to provide excellent knowledge and skills in both methodology and practical applications of clinical research. This is achieved using the principles of collaborative learning. Collaborative learning is an educational technique in which learners/students work together to solve a problem, complete a task or discuss an idea. This method is based on the notion that learning occurs naturally through social interactions, during the process of active communication. The process of gaining knowledge is dynamic, with a constant exchange of ideas between both student and teacher.

An integrative setting of innovative web 2.0 based learning technology and collaborative learning methods provides an optimal environment for multi-modal interactive training in clinical research and creates a unique global network of clinical scientists to provide a platform for international research collaborations.

The Master’s Program in Clinical Research MPCR is a two-year part-time program which includes 6 separate modules extending over the first three semesters, followed by a Master's Thesis which has to be completed within the fourth semester.

Module 1: BASICS OF CLINICAL RESEARCH

  • Introduction to Clinical Trials 
  • Selection of the Question
  • Study Population
  • Basic Study Design
  • Ethical and Regulatory Issues
  • Study Blinding
  • The Randomization Process
  • Recruitment of Study Participants
  • Participant Adherence

Module 2: STATISTICS

  • Statistics – Basics
  • Statistical Tests I+II
  • Sample Size
  • Survival Analysis
  • Other Issues in Statistics I+II

Module 3: PRACTICAL ASPECTS OF CLINICAL RESEARCH 

  • Integrity in Research
  • The Business of Clinical Research
  • Being a Clinical and Translational Scientist: Practical Challenges and Recommendations 
  • Design and Analysis of Surveys
  • Assessing Risk and Adverse Effects bin Clinical Research
  • Phase III and Multicenter Trials
  • Manuscript Submission

Module 4: STUDY DESIGNS 

  • International/Global Research
  • Special Panel: RCT vs. Observational Designs – How to choose?
  • Observational Studies
  • Confounders in Observational Studies: Using the Method of Propensity Score
  • Designs with Medical Devices and Interim Analysis
  • Non-Inferiority Designs

Module 5: WORKSHOPS

Review and discussion of material presented throughout the year in a detailed and intensive fashion.

Module 6: RESEARCH ORGANIZATION AND PRESENTATION

  • Clinical Pharmacological Trials
  • Financial and Economic Aspects of Clinical Research

After finishing these modules students will complete their Master's Thesis on a topic in the field of Clinical Research supervised by lecturers of the Master's Program.

Program Directors

 

Ben Illigens, MD

Instructor in Neurology
Beth Israel Deaconess Medical Center Boston, MA United States and
Director, German Sites Development Principles and
Practice of Clinical Research Harvard T.H. Chan School of Public Health

 

PD Dr. med. Timo Siepmann

Clinical neurologist Department of Neurology University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany and
Site Director (Dresden) Principles and
Practice of Clinical Research Harvard T.H. Chan School of Public Health

Teaching Staff

Our faculty and staff are internationally recognized for their teaching in clinical research.

Lecturers (excerpt)

  • PD Dr. med. Timo Siepmann

  • Ben Illigens, MD

  • Marc Eisele
    Director Centre for Media Technology in Medicine
    Carl Gustav Carus University Hospital

  • Ingeborg Friehs, MD
    Instructor in Surgery Department of Cardiac Surgery Children's Hospital Boston, Harvard Medical School, Boston United States

  • Prof. Dr. med. Martin Siepmann
    Professor of Clinical Pharmacology Neurologist (board certified), Psychiatrist (board certified), Clinical Pharmacologist (board certified), Psychosomatician (board certified) Carl Gustav Carus University Hospital Technische Universität Dresden and Director Department of Psychosomatic Medicine and Psychotherapy Rhoen Hospital Bad Neustadt Dresden and Bad Kissingen, Germany

  • Grace Yu, PhD
    Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM) University of Oxford, Oxford United Kingdom

  • Prof. Dr. Bernhard Schipp
    Professor of Business and Economics Quantitative Methods, esp. Econometrics, Technische Universität Dresden, Dresden Germany

  • Alexandra Pintér, MD, PhD
    Assistant professor of physiology Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Budapest Hungary

Teaching Assistants (TA)

  • Miluska Bromley, MD, MSc
    Senior TA, Plastic and Reconstructive Surgery Resident

  • Mohamed Hashim Mahmoud, MD, ABHS-FM
    Family Medicine, West Bay Training Center, Doha - Qatar

  • Arturo Tamayo, MD, FAHA
    Assistant Professor of Neurology University of Manitoba

Applicants to the Master’s Program in Clinical Research have to meet each of  the following admission requirements:

  • University’s degree (4 years)
  • Registration in the PPCR program offered by the Department of Continuing Education, Harvard T. H. Chan School of Public Health or Certificate of the PPCR program
  • Tuition payable to DIU upon acceptance into the Master’s program (MPCR)
  • PPCR alumni will have to provide a Certificate of the PPCR program and apply directly to DIU for the 2nd year of the Master’s program

To applicants who have already graduated from the PPCR course, a reduced Master’s program tuition of Euro 8,500. applies. All PPCR alumni have to submit their complete PPCR grading together with their application. For questions regarding the application process send an e-mail to clinical.research@di-uni.de.

A list of orginal articles that have arisen from Master’s theses submitted by graduates of our program.
We closely supervise our Master’s students in drafting publications since it is one of our core missions to take research education from a theoretical to a practical level and help our students publish original research. To foster effectivenes and teamwork in clinical research we offer to our students the opportunity to submit a research paper instead of a traditional „regular“  Master’s thesis to receive the Master’s of Science degree. Thus our students receive maximal benefits from our program: thez optimize their skills in conducting research and drafting manuscripts and, in addition to this theoretical training, they are acutally getting published and thus improve their scientific career.

  • Fasslrinner F, Schetelig J, Burchert A, Kramer M, Trenschel R, Hegenbart U, Stadler M, Schäfer-Eckart K, Bätzel M, Eich H, Stuschke M, Engenhart-Cabillic R, Krause M, Dreger P, Neubauer A, Ehninger G, Beelen D, Berdel WE, Siepmann T, Stelljes M, Bornhäuser M. Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial. Lancet Haematol. 2018 Apr;5(4):e161-e169.
  • Heppt MV, Siepmann T, Engel J, Schubert-Fritschle G, Eckel R, Mirlach L, Kirchner T, Jung A, Gesierich A, Ruzicka T, Flaig MJ, Berking C. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. BMC Cancer. 2017 Aug 10;17(1):536
  • Riediger C, Schuster T, Barlinn K, Maier S, Weitz J, Siepmann T. Adverse Effects of Antidepressants for Chronic Pain: A Systematic Review and Meta-analysis. Front Neurol. 2017 Jul 14;8:307.
  • Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zähringer M, Suchorska B, Wenter V, Illigens BM, Bartenstein P, Albert NL. Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? EJNMMI Res. 2017 Dec;7(1):48.
  • Schnabel A, Range U, Hahn G, Siepmann T, Berner R, Hedrich CM. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children. Rheumatol Int. 2016 Dec;36(12):1737-1745.
  • Spieth PM, Kubasch AS, Penzlin AI, Illigens BM, Barlinn K, Siepmann T. Randomized controlled trials - a matter of design. Neuropsychiatr Dis Treat. 2016 Jun 10;12:1341-9.
  • Nassir M, Guan J, Luketina H, Siepmann T, Rohr I, Richter R, Castillo-Tong DC, Zeillinger R, Vergote I, Van Nieuwenhuysen E, Concin N, Marth C, Hall C, Mahner S, Woelber L, Sehouli J, Braicu EI. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study. Tumour Biol. 2015 Sep 29. [Epub ahead of print]
  • Woopen H, Richter R, Chekerov R, Siepmann T, Ismaeel F, Sehouli J. The influence of comorbidity and comedication on grade III/IV toxicity and prior discontinuation of chemotherapy in recurrent ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO). 2015, doi: 10.1016/j.ygyno.2015.07.007. [Epub ahead of print]
  • Zerna C, Siepmann T, Barlinn K, Kepplinger J, Pallesen LP, Puetz V, Bodechtel U. Association of time on outcome after intravenous thrombolysis in the elderly in a telestroke network. J Telemed Telecare. 2015 May 29. pii: 1357633X15585241. [Epub ahead of print]
  • Seidlitz A, Siepmann T, Löck S, Juratli T, Baumann M, Krause M. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme. Radiat Oncol. 2015 Aug 16;10:172.
  • Lohkamp LN, Öllinger R, Chatzigeorgiou A, Illigens BM, Siepmann T. Intraoperative biomarkers in renal transplantation. Nephrology (Carlton). 2015 Jul 1. doi: 10.1111/nep.12556. [Epub ahead of print]
  • Kepplinger J, Prakapenia A, Barlinn K, Siegert G, Gehrisch S, Zerna C, Beyer-Westendorf J, Puetz V, Reichmann H, Siepmann T, Bodechtel U. Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol. J Thromb Thrombolysis. 2015 May 23. [Epub ahead of print]
  • Barlinn K, Kepplinger J, Puetz V, Illigens BM, Bodechtel U, Siepmann T. Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis. Neuropsychiatr Dis Treat. 2015,11:1-14

http://www.ncbi.nlm.nih.gov/m/pubmed/

Upcoming Events

Keine Artikel in dieser Ansicht.

Netzwerkpartner: